TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: Importantly, KEGG pathway analysis shows an impressive functional association of Group A miRNA targets with various cancer-related pathways, such as pathways in cancer (P = 2.09 × 10−5), colorectal cancer (P = 1.42 × 10−3), p53 signaling pathway (P = 4.55 × 10−3), small cell lung cancer (P = 1.58 × 10−2), endocytosis (P = 3.37 × 10−2), TGF-beta signaling pathway (P = 2.32 × 10−2), chronic myeloid leukemia (P = 2.58 × 10−2) as well as cell cycle (P = 2.31 × 10−2), and prostate cancer (P = 2.11 × 10−2) (Figure 3(c)).